A LIFESAVING TEST FOR WOMEN’S CANCERS
Thanks to the immense generosity of our donors and volunteers, the DOvEE campaign surpassed its $2 million goal! With your support, Dr. Gilbert and her team are one step closer to making the DOvEEgene test a standard of women’s care.
The DOvEEgene test, as routine as a pap smear, can detect cancer using DNA analysis before it becomes a death sentence. The final DOvEEgene clinical trial began in Spring 2021 and has recruited over 1,000 women to help prove the lifesaving power of the DOvEEgene test. The trial will last three years and enroll 3,600 women. When it is complete, the team will apply for Health Canada approval to make the test available to women everywhere.
Thank you to key donors The Blachford Company, the Carole Epstein Foundation, Ilana Cohen, the Debay and Moussalier family, the Gagliardi family, Esthel Gravel, Paula Gillett, the Green family, Micol Haimson, the Henry and Berenice Kaufmann Foundation, Anne Lafleur, the Léger Family Foundation, the Lyceum of Greek Women of Montreal, The Marchand family, Ewelina Pawlak and Nicolas Fortin, Joanne Photiades, Julie Snyder, Danièle Thibodeau and so many others who shared our big dream to ensure no more mothers, daughters, sisters and friends are lost to ovarian cancer.
.png)
Help Us Stop the Silent Killer.
Thousands of Canadian women are diagnosed with ovarian and endometrial cancers each year. A breakthrough led by the MUHC’s Dr. Lucy Gilbert promises to radically reduce this threat to women’s lives.
